Price $82.11 |
Market Cap
4.14B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
71.1
|
P/B
7.63
|
P/S
10.55
|
Dividend %
-
|
|
P/CF
187.6
|
P/FCF
94.6
|
Op. Cash Flow
61.7K
|
FCF
0.8
|
|
Op. Margin
17.80%
|
Net Margin
14.80%
|
ROE
11.50%
|
ROI
9.00%
|
|
ROA
10.30%
|
EPS Growth
38.70%
|
Current Ratio
8.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 10M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $0.31 | - | - | 24.7M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $22.93 | - | 3.50% | 24.52B | Strong Buy |
| Bovie Medical Corporation (BVX) | $5.23 | - | - | 144.7M | Strong Buy |
| Misonix, Inc. (MSON) | $13.50 | - | - | 119.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
